MedTrace Logo

Impact of Different Dialysis on Sleep Apnea in Patients With Renal Failure

NCT00380848 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2007-04-12

No results posted yet for this study

Summary

The purpose of this study is to determine whether hemodiafiltration, a new form of hemodialysis can improve sleep apnea in patients with end stage kidney disease.

Conditions

Interventions

PROCEDURE

Hemodiafiltration

Sponsors & Collaborators

  • Gambro Renal Products, Inc.

    collaborator INDUSTRY

  • McGill University

    collaborator OTHER

  • McGill University Health Centre/Research Institute of the McGill University Health Centre

    lead OTHER

Principal Investigators

  • Kateri A Champagne, M.D. · McGill University Health Centre/Research Institute of the McGill University Health Centre

  • Navdeep Tangri, M.D. · McGill University

  • John R Kimoff, M.D. · McGill University Health Centre/Research Institute of the McGill University Health Centre

  • Paul Barre, M.D. · McGill University Health Centre/Research Institute of the McGill University Health Centre

  • Sameena Iqbal, M.D. · McGill University Health Centre/Research Institute of the McGill University Health Centre

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-03-31
Completion
2007-12-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00380848 on ClinicalTrials.gov